BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 3387374)

  • 21. Studies on sustained-release suppositories. III. Rectal absorption of morphine in rabbits and prolongation of its absorption by alginic acid addition.
    Kawashima S; Inoue Y; Shimeno T; Fujiwara H
    Chem Pharm Bull (Tokyo); 1990 Feb; 38(2):498-505. PubMed ID: 2337965
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modification of rectal absorption of morphine from hollow-type suppositories with a combination of alpha-cyclodextrin and viscosity-enhancing polysaccharide.
    Uekama K; Kondo T; Nakamura K; Irie T; Arakawa K; Shibuya M; Tanaka J
    J Pharm Sci; 1995 Jan; 84(1):15-20. PubMed ID: 7714736
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasma concentrations following single doses of morphine sulfate in oral solution and rectal suppository.
    Ellison NM; Lewis GO
    Clin Pharm; 1984; 3(6):614-7. PubMed ID: 6548939
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Analgesic activity of morphine suppository in rats].
    Kita A; Nakamura H; Kadokawa T; Tan T
    Yakugaku Zasshi; 1990 May; 110(5):349-53. PubMed ID: 2376826
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Further development of a morphine hydrogel suppository.
    Cole L; Hanning CD; Robertson S; Quinn K
    Br J Clin Pharmacol; 1990 Dec; 30(6):781-6. PubMed ID: 2288824
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bioavailability of indomethacin after intramuscular injection and rectal administration of solution and suppositories.
    Jensen KM; Grenabo L
    Acta Pharmacol Toxicol (Copenh); 1985 Nov; 57(5):322-7. PubMed ID: 4090993
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Plasma concentrations and bioavailability of propranolol by oral, rectal, and intravenous administration in man.
    Cid E; Mella F; Lucchini L; Cárcamo M; Monasterio J
    Biopharm Drug Dispos; 1986; 7(6):559-66. PubMed ID: 3828485
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Population pharmacokinetics of morphine and morphine-6-glucuronide following rectal administration--a dose escalation study.
    Brokjær A; Kreilgaard M; Olesen AE; Simonsson US; Christrup LL; Dahan A; Drewes AM
    Eur J Pharm Sci; 2015 Feb; 68():78-86. PubMed ID: 25486331
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Randomized, double-blind, placebo-controlled study of the effect of rectal paracetamol on morphine consumption after abdominal hysterectomy.
    Kvalsvik O; Borchgrevink PC; Hagen L; Dale O
    Acta Anaesthesiol Scand; 2003 Apr; 47(4):451-6. PubMed ID: 12694145
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Pharmacokinetic effects in morphine toxicity, with case examples].
    Morant R; Senn HJ
    Schweiz Rundsch Med Prax; 1991 Jun; 80(26):719-22. PubMed ID: 1862260
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The bioavailability of intramuscularly administered nicomorphine (Vilan) with its metabolites and their glucuronide conjugates in surgical patients.
    Koopman-Kimenai PM; Vree TB; Booij LH; Dirksen R
    Int J Clin Pharmacol Ther; 1995 Aug; 33(8):442-8. PubMed ID: 8556223
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Morphine pharmacokinetics after pulmonary administration from a novel aerosol delivery system.
    Ward ME; Woodhouse A; Mather LE; Farr SJ; Okikawa JK; Lloyd P; Schuster JA; Rubsamen RM
    Clin Pharmacol Ther; 1997 Dec; 62(6):596-609. PubMed ID: 9433388
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bioavailability of morphine from rectal suppositories.
    Lipman AG; Anderson BD
    Am J Hosp Pharm; 1984 Apr; 41(4):636, 638. PubMed ID: 6720701
    [No Abstract]   [Full Text] [Related]  

  • 34. Comparison of bioavailability in man of tamoxifen after oral and rectal administration.
    Tukker JJ; Blankenstein MA; Nortier JW
    J Pharm Pharmacol; 1986 Dec; 38(12):888-92. PubMed ID: 2880961
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The influence of rectal cisapride on morphine-induced gastric stasis.
    Kluger MT; Plummer JL; Owen H
    Anaesth Intensive Care; 1991 Aug; 19(3):346-50. PubMed ID: 1767901
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Systemic absorption of nebulized morphine compared with oral morphine in healthy subjects.
    Masood AR; Thomas SH
    Br J Clin Pharmacol; 1996 Mar; 41(3):250-2. PubMed ID: 8866928
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Single-dose kinetics and bioavailability of ketobemidone.
    Anderson P; Arnér S; Bondesson U; Boréus LO; Hartvig P
    Acta Anaesthesiol Scand Suppl; 1982; 74():59-62. PubMed ID: 6124079
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Absorption and bioavailability of nebulized morphine.
    Chrubasik J; Wüst H; Friedrich G; Geller E
    Br J Anaesth; 1988 Aug; 61(2):228-30. PubMed ID: 3415896
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An evaluation of the effect of food on the oral bioavailability of sustained-release morphine sulfate tablets (ORAMORPH SR) after multiple doses.
    Bass J; Shepard KV; Lee JW; Hulse J
    J Clin Pharmacol; 1992 Nov; 32(11):1003-7. PubMed ID: 1474160
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Design of controlled-release morphine suppositories containing polyglycerol ester of fatty acid.
    Takatori T; Yamamoto K; Yamaguchi T; Higaki K; Kimura T
    Biol Pharm Bull; 2005 Aug; 28(8):1480-4. PubMed ID: 16079497
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.